Drugs & Devices
Dupixent Use Linked to Higher Risk of Rare Skin Lymphoma, Studies Show
Studies link Dupixent to an increased risk of cutaneous T-cell lymphoma. The FDA is reviewing safety reports as patients and doctors weigh concerns.